-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVARTIS CANADA: RECEIVES HEALTH CANADA APPROVAL FOR VANRAFIA FOR PROTEINURIA REDUCTION IN ADULTS WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY

路透·07/13/2026 18:01:37

登錄查看新聞詳情